173 studies found for:    "gastrointestinal stromal tumor"
Show Display Options
Rank Status Study
21 Completed Imatinib Mesylate in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed By Surgery
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: imatinib mesylate;   Other: placebo;   Other: laboratory biomarker analysis
22 Active, not recruiting Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Interventions: Biological: bevacizumab;   Drug: imatinib mesylate;   Other: laboratory biomarker analysis;   Other: pharmacological study
23 Recruiting Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions
Conditions: Chronic Myeloid Leukemia;   Gastrointestinal Stromal Tumor
Intervention: Drug: Imatinib Mesylate Tablets, 400 mg
24 Active, not recruiting Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: imatinib mesylate
25 Terminated Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery
Condition: Gastrointestinal Stromal Tumor
Interventions: Biological: oblimersen sodium;   Drug: imatinib mesylate;   Other: laboratory biomarker analysis
26 Recruiting Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot be Removed by Surgery or Are Metastatic
Conditions: Chondrosarcoma;   Clear Cell Sarcoma of the Kidney;   Endometrial Stromal Sarcoma;   Ewing Sarcoma of Bone;   Extraosseous Ewing Sarcoma;   Gastrointestinal Stromal Tumor;   Mast Cell Sarcoma;   Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Metastatic Osteosarcoma;   Ovarian Sarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Recurrent Osteosarcoma;   Recurrent Uterine Sarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage III Uterine Sarcoma;   Stage IV Adult Soft Tissue Sarcoma;   Stage IV Uterine Sarcoma
Interventions: Drug: dasatinib;   Biological: ipilimumab;   Other: laboratory biomarker analysis;   Other: pharmacological study
27 Active, not recruiting Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors
Conditions: Carney Complex;   Chondrosarcoma;   Gastrointestinal Stromal Tumor;   Paraganglioma
Interventions: Drug: linsitinib;   Other: pharmacological study;   Other: laboratory biomarker analysis
28 Terminated
Has Results
Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients
Conditions: Gastrointestinal Stromal Tumors,;   Cancer,;   Solid Tumors
Interventions: Drug: Peginterferon-alpha 2b (PegIFNa2b);;   Drug: Imatinib
29 Completed Gastrointestinal Stromal Tumors (GIST) Registry
Condition: Gastrointestinal Stromal Tumors
Intervention: Other: GIST Registry
30 Recruiting MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)
Condition: Gastrointestinal Stromal Tumor (GIST)
Interventions: Drug: MEK162;   Drug: Imatinib Mesylate (Gleevec®; STI571; NSC #716051)
31 Recruiting A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Sunitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib
Condition: Gastrointestinal Stromal Tumors
Interventions: Drug: Masitinib;   Drug: Sunitinib
32 Terminated
Has Results
Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: sunitinib malate;   Drug: imatinib mesylate
33 Completed Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Glivec
34 Completed Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting
Condition: Gastrointestinal Stromal Tumors
Intervention:
35 Completed Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Everolimus + Imatinib
36 Completed Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Imatinib Mesylate
37 Completed Phase II Study Aiming to Evaluate the Efficacy and Safety of Nilotinib Patients With Gastrointestinal Stromal Tumors (GIST) Resistant or Intolerant to Imatinib and or to 2nd Line Tyrosine Kinas (TK) Inhibitor
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: AMN107- NILOTINIB
38 Completed Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: AMN107, STI571
39 Active, not recruiting Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors
Conditions: Advanced Renal Cell Carcinoma;   Gastrointestinal Stromal Tumors;   Pancreatic Neuroendocrine Tumors
Intervention: Drug: TH-302
40 Completed
Has Results
The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).
Conditions: Gastrointestinal Stromal Tumors;   Soft Tissue Sarcomas
Intervention: Drug: AZD2171

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years